CN103656486A - Drug for treating psoriasis - Google Patents
Drug for treating psoriasis Download PDFInfo
- Publication number
- CN103656486A CN103656486A CN201210369052.7A CN201210369052A CN103656486A CN 103656486 A CN103656486 A CN 103656486A CN 201210369052 A CN201210369052 A CN 201210369052A CN 103656486 A CN103656486 A CN 103656486A
- Authority
- CN
- China
- Prior art keywords
- parts
- drug
- rhizoma
- radix
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a drug for treating psoriasis, belonging to the technical field of traditional Chinese medicine preparations. The drug is mainly composed of 16 crude drugs such as honeysuckle, oldenlandia, fructus forsythiae, dictamnus dasycarpus, rhizoma smilacis glabrae, rhizoma sparganii, radix sophorae flavescentis, fructus kochiae, salvia miltiorrhiza and the like. The drug can be processed into capsules, tablets, pills, granules, oral liquid and other different dosage forms for later use. The drug has the effects of clearing away heat and toxic materials, dispelling the wind and removing dampness, promoting blood circulation and removing blood stasis and the like; and proved by clinical application, the drug is exact in curative effect for psoriasis, free of toxic and side effects and easy to develop, popularize and apply.
Description
Technical field
The invention belongs to Chinese medicine preparation technical field.
Background technology
Psoriasis is also psoriasis, is a kind of non-infectious, chronic and have the erythroderma desquamativum of tendency of recurrence, often occurs erythra erythema on patient skin, above has squama, and abscess appears in part, time heavy when light, touching difficulty is more.Chinese and western medicine does not also have ideal curative effect to psoriatic treatment at present.
Summary of the invention
In order to overcome the deficiencies in the prior art, the invention provides a kind of psoriatic medicine for the treatment of.The present invention has the effect of heat-clearing and toxic substances removing, expelling wind and removing dampness, blood circulation promoting and blood stasis dispelling, to psoriatic treatment, can reach determined curative effect, have no side effect, takes easy object.
The present invention solves the technology incidence of criminal offenses that its technical problem adopts: Flos Lonicerae, Herba Hedyotidis Diffusae, Fructus Forsythiae, Cortex Dictamni, Herba Taraxaci, Rhizoma Smilacis Glabrae, Rhizoma Sparganii, Rhizoma Curcumae, Radix Rehmanniae, Rhizoma Imperatae, Radix Sophorae Flavescentis, Radix Saposhnikoviae, the Fructus Kochiae, Radix Salviae Miltiorrhizae, Caulis Spatholobi, 16 kinds of crude drug of Radix Angelicae Sinensis, consist of.
In preparation of the present invention about ingredient major function and preparation:
Flos Lonicerae in the present invention, nature and flavor are sweet, cold.Containing Flos Lonicerae glycoside, luteolin, inositol, Saponin etc.Heat-clearing and toxic substances removing.Cure mainly epidemic febrile disease heating, carbuncle, scabies, malignant boil, toxic swelling, toxic-heat and blood stasis, pneumonia, laryngopharynx swelling and pain, wind heat sense stomach etc.
Herba Hedyotidis Diffusae in the present invention, nature and flavor are bitter, sweet, cool.Containing hentriacontane, stigmasterol, maloic acid, oleanolic acid etc.Heat-clearing and toxic substances removing, diuresis of blood circulation promoting.Cure mainly appendicitis and various inflammation, venom etc.
Fructus Forsythiae in the present invention, nature and flavor are bitter, cold.Containing Saponin, phenol glycoside, alkaloid, Citrin etc.Heat-clearing and toxic substances removing, mass dissipating and swelling eliminating, evacuation of pus.Cure mainly calentura from the beginning of, skin infection, scrofula, erysipelas, pyretic stranguria, macule, urine stranguria with urinary obstruction.
Cortex Dictamni in the present invention, nature and flavor are bitter, cold.Containing Cortex Dictamni alkali, Cortex Dictamni lactone, Saponin, volatile oil, sitosterol, Cortex Phellodendri lactone, flavone.Heat clearing and damp drying, the removing toxic substances of dispeling the wind.Cure mainly damp and hot sore, pus all over nest, yellow fluid is dripping, and skin itching, skin ulcer tinea mange, pudendum swells and ache.
Herba Taraxaci in the present invention, nature and flavor are bitter, sweet, cold.Containing taraxol, taraxacin, taraxacin, glucose, pectin, choline, caffeic acid, inositol, amaroid, Saponin, resin etc.Heat clearing away, removing toxic substances, eliminating stagnation.Cure mainly taste stagnated fire, acute mastitis, pyretic stranguria, scrofula, lymphadenitis.
Rhizoma Smilacis Glabrae in the present invention, nature and flavor are sweet, light, flat.Containing multiple steroid saponin, alkaloid, volatile oil, saccharide, resin, starch etc.Dampness removing, removing toxic substances.Cure mainly Fructus Myricae rubrae skin infection, muscles and bones spasm and pain, scrofula carbuncle, antimercurialism.
Rhizoma Sparganii in the present invention, nature and flavor are bitter, flat.Containing volatile oil, starch etc.Removing blood stasis circulation of qi promoting, removing food stagnancy, stimulates the menstrual flow, pain relieving.Cure mainly lump in the abdomen, coagulation of QI-blood, chest and abdomen swelling and pain, women's amenorrhea, postnatal blood stasis stomachache.
Rhizoma Curcumae in the present invention, has another name called Rhizoma Curcumae, and nature and flavor are bitter, pungent, temperature.Containing volatile oil, stigmasterol, triterpenic acid, resin, phlegmatic temperament, starch etc.Circulation of qi promoting removing blood stasis, removing food stagnancy pain relieving, antitumor.Cure mainly coagulation of QI-blood, blood stasis amenorrhea, lump in the abdomen, abdominal distention, traumatic injury, cervical cancer, carcinoma vulvae.
Radix Rehmanniae in the present invention, nature and flavor are sweet, cold.Containing mannitol, glucose, alkaloid, fatty acid, vitamin A, rehmanin, catalpol etc.YIN nourishing, pathogenic fire reducing, hemopoietic, removing heat from blood.Cure mainly epidemic febrile disease impairment of YIN, large hot excessive thirst, macule, quenches one's thirst, bleeding due to blood-heat.
Rhizoma Imperatae in the present invention, nature and flavor are sweet, cold.Containing mannitol, glucose, fructose, sucrose, citric acid, malic acid, potassium chloride, Cylindrin, organic acid etc.Clearing away heat and cooling blood, relieving stranguria by diuresis.Cure mainly interior-heat excessive thirst, hematemesis and epistaxis, dysuria, pyretic stranguria hematuria.
Radix Sophorae Flavescentis in the present invention, nature and flavor are bitter, Great Cold.Containing matrine, oxymatrine, caulophylline, anagyrine etc.Clearing away heat and cooling blood, wind dispelling insecticide.Cure mainly stranguria with blood, jaundice, yellowish or reddish urine, skin wind heat, malignant boil mange.
Radix Saposhnikoviae in the present invention, nature and flavor are pungent, sweet, temperature.Containing volatile oil, mannitol, phenolic substance and polysaccharide etc.Deliver, dispel the wind, victory is wet.Cure mainly affection of exogenous wind-cold, headache, dizzy, general aching, rheumatic arthralgia, extremity contraction is anxious.
The Fructus Kochiae in the present invention, nature and flavor are sweet, and hardship is cold.Containing triterpenoid saponin, vitamin A, protein and fatty wet goods.Diuresis, clearing away damp-heat.Cure mainly treatment by oral administration of medicines damp-heat in the urinary bladder, dysuria, gonorrhea, leukorrhagia, hernia; External treatment skin wind heat, pruritus, sore, pudendum pruritus due to damp pathogen.
Radix Salviae Miltiorrhizae in the present invention, nature and flavor are bitter, are slightly cold.Containing TANSHINONES first, TANSHINONES second, TANSHINONES the third, pigment, vitamin E.Eliminating blood stasis to promote regeneration of blood, promoting blood flow to regulate menstruation.Cure mainly menoxenia, menalgia, carbuncle erysipelas.
Caulis Spatholobi in the present invention, nature and flavor are bitter, sweet, temperature.Contain milletol etc.The promoting the circulation of blood of enriching blood, the meridian dredging, bone and muscle strengthening.Cure mainly blood deficiency paralysis and numbness, soreness of waist and knee joint, menoxenia.
Radix Angelicae Sinensis in the present invention, sweet, pungent, temperature.Containing volatile oil, brown eleostearic acid, sucrose, vitamin B
12, nicotinic acid, vitamin E etc.Enrich blood and invigorate blood circulation, blood stasis dispersing and fresh blood promoting, regulating menstruation is moisturized.Cure mainly headache due to deficiency of blood, lumbago, all pains of trusted subordinate, constipation due to dry stool, flaccidity syndrome and arthralgia syndrome, lump in the abdomen, ulcer sores, amenorrhea, through coming abdomen pain, metrorrhagia.
The psoriatic cause of disease is generally to experience wind, wet, cold, hot all heresies, and visitor is in space between skin and muscles, accumulate long-pending loose, finally turn to scorchingly hot, rich mutually with vim and vigour, hematogenous blockage, prolonged illness becomes the stasis of blood, forms persistent ailment.Psoriatic skin lesion shows as erythema and does not move back lastingly, and the dry first in affected part is wrong, and heap of white scale is tied mutually therefore its pathogenesis be poison, heat, wind, the stasis of blood, and in skin, is sufferer end.The present invention has the effect of heat-clearing and toxic substances removing, expelling wind and removing dampness, blood blood stasis dispelling, therefore psoriasis is had to good therapeutic effect.
The invention has the beneficial effects as follows: through clinical practice proof, to psoriasis determined curative effect, have no side effect, easily develop and spread application.
The specific embodiment
1. fill a prescription and part by weight: 30 parts of Flos Loniceraes, 20 parts of Herba Hedyotidis Diffusaes, 15 parts of Fructus Forsythiaes, 10 parts of Cortex Dictamni, 15 parts of Herba Taraxacis, 20 parts of Rhizoma Smilacis Glabraes, 10 parts of Rhizoma Sparganii, 10 parts of Rhizoma Curcumae, 20 parts of Radix Rehmanniae, 30 parts of Rhizoma Imperataes, 15 parts of Radix Sophorae Flavescentiss, 10 parts of Radix Saposhnikoviaes, 15 parts of the Fructus Kochiae, 15 parts of Radix Salviae Miltiorrhizaes, 15 parts of Caulis Spatholobis, 10 parts of Radix Angelicae Sinensis.
2. above-mentioned 16 kinds of crude drug are weighed and assorted in proportion, it is qualified with pharmaceutical equipment apparatus, to concoct, and purifies, and concentrated, mix homogeneously post-treatment becomes the different dosage forms such as capsule, tablet, pill, granule, oral liquid standby
Claims (1)
1. the psoriatic medicine for the treatment of, is characterized in that crude drug formula and part by weight are 30 parts of Flos Loniceraes, 20 parts of Herba Hedyotidis Diffusaes, 15 parts of Fructus Forsythiaes, 10 parts of Cortex Dictamni, 15 parts of Herba Taraxacis, 20 parts of Rhizoma Smilacis Glabraes, 10 parts of Rhizoma Sparganii, 10 parts of Rhizoma Curcumae, 20 parts of Radix Rehmanniae, 30 parts of Rhizoma Imperataes, 15 parts of Radix Sophorae Flavescentiss, 10 parts of Radix Saposhnikoviaes, 15 parts of the Fructus Kochiae, 15 parts of Radix Salviae Miltiorrhizaes, 15 parts of Caulis Spatholobis, 10 parts of Radix Angelicae Sinensis; Above-mentioned raw materials medicine is weighed and is assorted in proportion, with pharmaceutical equipment apparatus concoct qualified, purify, concentrated, mix homogeneously post-treatment becomes capsule, tablet, pill, oral liquid different dosage form.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210369052.7A CN103656486A (en) | 2012-09-14 | 2012-09-14 | Drug for treating psoriasis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210369052.7A CN103656486A (en) | 2012-09-14 | 2012-09-14 | Drug for treating psoriasis |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103656486A true CN103656486A (en) | 2014-03-26 |
Family
ID=50296044
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210369052.7A Pending CN103656486A (en) | 2012-09-14 | 2012-09-14 | Drug for treating psoriasis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103656486A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104800649A (en) * | 2015-05-11 | 2015-07-29 | 李汶峰 | Traditional Chinese medicine for treating psoriasis |
CN110170035A (en) * | 2019-03-14 | 2019-08-27 | 首都医科大学附属北京中医医院 | Pharmaceutical composition, pharmaceutical preparation and the application for treating psoriasis vulgaris |
-
2012
- 2012-09-14 CN CN201210369052.7A patent/CN103656486A/en active Pending
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104800649A (en) * | 2015-05-11 | 2015-07-29 | 李汶峰 | Traditional Chinese medicine for treating psoriasis |
CN110170035A (en) * | 2019-03-14 | 2019-08-27 | 首都医科大学附属北京中医医院 | Pharmaceutical composition, pharmaceutical preparation and the application for treating psoriasis vulgaris |
CN110170035B (en) * | 2019-03-14 | 2021-11-02 | 首都医科大学附属北京中医医院 | Pharmaceutical composition for treating psoriasis vulgaris, pharmaceutical preparation and application |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101791377B (en) | Traditional Chinese medicine preparation for post-operation rehabilitation of cervicitis and cervical hypertrophy | |
CN104324338A (en) | Nursing patch for bedsore | |
CN102008610B (en) | Traditional Chinese medicine composition for curing hyperosteogeny | |
CN103341079A (en) | Chinese medicine composition for treating acne | |
CN102178922A (en) | Traditional Chinese medicine composition for treating dysmenorrhea and preparation method thereof | |
CN104435168A (en) | Drug for treating pressure sores | |
CN102526259A (en) | Drug for curing rheumatoid arthritis | |
CN103751691A (en) | Medicine for treating eczema | |
CN103751544A (en) | Topically applied paste for treating bedsore | |
CN102416126A (en) | Chinese medicinal combination preparation for treating behcet syndrome and preparation method of Chinese medicinal combination preparation | |
CN103656486A (en) | Drug for treating psoriasis | |
CN104258360A (en) | Traditional Chinese medicine combination for curing menstrual colic and preparation method of preparations thereof | |
CN102343019B (en) | Chinese medicinal composition for treating amenorrhea and preparation method of preparation thereof | |
CN101953930B (en) | Externally-applied traditional Chinese medicine for treating tinea capitis | |
CN104095947A (en) | Traditional Chinese medicine preparation for treating scapulohumeral periarthritis | |
CN103656525A (en) | Traditional Chinese medicinal composition for treating dysmenorrhea | |
CN103316099B (en) | Gynecologic inflammation treatment spray | |
CN103656090B (en) | A kind of enema and application thereof for the treatment of ulcerative colitis | |
CN105521082A (en) | Traditional Chinese medicinal preparation for treating eczema with syndrome of wind heat | |
CN104491670A (en) | Traditional Chinese medicine composition for treating chronic pelvic inflammatory disease | |
CN104225100A (en) | Drug for treating knee osteoarthritis | |
CN103239678A (en) | External traditional Chinese medicine liniment for treating acnes | |
CN102872290B (en) | Chinese medicament for treating menstrual disorder | |
CN102028768A (en) | Traditional Chinese medicament for treating lumbar canal stenosis | |
CN105878557A (en) | Herbal preparation for treating seborrhea dermatitis due to yin-deficiency stagnation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140326 |